19Feb/13

Novartis nabs another FDA-approved indication for everolimus – FiercePharma


MedPage Today

Novartis nabs another FDA-approved indication for everolimus
FiercePharma
Turns out, everolimus is becoming quite the franchise for Novartis ($NVS). Sold under the Afinitor and Votubia names for tumor treatment and as Zortress and Certican for transplant patients, everolimus is one of the Swiss drugmaker’s lead drugs in the
FDA Approves Everolimus for Liver RejectionMedPage Today
Novartis’ Zortress cleared by FDA for liver transplantsPMLiVE
Novartis drug Zortress is first in over a decade approved by FDA to prevent PipelineReview.com (press release)
Monthly Prescribing Reference –Motley Fool –PharmaTimes
all 9 news articles »
19Feb/13

Another Event to Spread Awareness of Organ Donation – French Tribune


French Tribune

Another Event to Spread Awareness of Organ Donation
French Tribune
Organ donation is a generous act that gives another person a hope to live. Aiming to spread the importance of organ donation, the Marie Claire South Africa , Organ Donor Foundation has once again stepped out to convince the celebs to strip down to
From The Heart: Record numbers join the NHS Organ Donation RegisterITV News
Former teacher takes part in ITV campaign ‘From the Heart’Basingstoke Gazette

all 3 news articles »

19Feb/13

ALLENEX AB : US breakthrough order for Allenex with SBT Resolver™ – 4-traders (press release)

ALLENEX AB : US breakthrough order for Allenex with SBT Resolver™
4-traders (press release)
“This is a breakthrough event and a major step forward regarding our sales of SBT Resolver™ for HLA typing for bone marrow transplants” says Anders Karlsson, CEO of Allenex. “We are happy and proud to be able to meet the expectations from this top HLA

and more »